Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mehr Darou Pharmaceutical is a prominent Iranian pharmaceutical manufacturer based in Tehran, specializing in the production of generic medicines and herbal-based therapeutic products. Founded in 1984, the company operates under the umbrella of the Tamin Pharmaceutical Investment Company (TPICO) and maintains a significant presence in the domestic healthcare market. Their product portfolio encompasses a wide range of therapeutic areas, including cardiovascular, metabolic, gastrointestinal, and respiratory health, delivered through various dosage forms such as tablets, capsules, and syrups. Mehr Darou is notably recognized for its expertise in herbal medicine, producing standardized extracts and formulations that bridge traditional remedies with modern clinical standards. The company's manufacturing facilities adhere to international Good Manufacturing Practice (GMP) guidelines to ensure the quality and safety of its diverse pharmaceutical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mehr Darou Pharmaceutical.